Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee A Hebert

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Kidney International|March 11, 2011
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rateSergey V Brodsky, Tibor Nadasdy, Brad H Rovin, et al.
Journal of Hypertension|November 6, 2019
Masked uncontrolled hypertensionJuan M Mejia-Vilet, Udayan Bhatt, Daniel J Birmingham, et al.
Nephron. Clinical Practice|April 24, 2010
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney diseaseSergey V Brodsky, Michael Collins, Edward Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypesYee Ling Wu, Stephanie L Savelli, Yan Yang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 25, 2015
Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its FlareDaniel J Birmingham, Joshua E Bitter, Ezinne G Ndukwe, et al.
American Journal of Hypertension|July 16, 2014
Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?Kyle M Ware, Jay C Vance, Navin Muni, et al.
Annals of the Rheumatic Diseases|October 5, 2013
Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular diseaseDaniel J Birmingham, Ganesh Shidham, Annalisa Perna, et al.
Arthritis and Rheumatism|September 30, 2006
Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G alleleDaniel J Birmingham, H N Nagaraja, Brad H Rovin, et al.
Journal of the American Society of Nephrology : JASN|September 3, 2011
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulationKyle Ware, Polina Brodsky, Anjali A Satoskar, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 11, 2012
Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?Brad H Rovin, Samir V Parikh, Lee A Hebert, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Kidney International|March 11, 2011
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rateSergey V Brodsky, Tibor Nadasdy, Brad H Rovin, et al.
Journal of Hypertension|November 6, 2019
Masked uncontrolled hypertensionJuan M Mejia-Vilet, Udayan Bhatt, Daniel J Birmingham, et al.
Nephron. Clinical Practice|April 24, 2010
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney diseaseSergey V Brodsky, Michael Collins, Edward Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypesYee Ling Wu, Stephanie L Savelli, Yan Yang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 25, 2015
Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its FlareDaniel J Birmingham, Joshua E Bitter, Ezinne G Ndukwe, et al.
American Journal of Hypertension|July 16, 2014
Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?Kyle M Ware, Jay C Vance, Navin Muni, et al.
Annals of the Rheumatic Diseases|October 5, 2013
Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular diseaseDaniel J Birmingham, Ganesh Shidham, Annalisa Perna, et al.
Arthritis and Rheumatism|September 30, 2006
Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G alleleDaniel J Birmingham, H N Nagaraja, Brad H Rovin, et al.
Journal of the American Society of Nephrology : JASN|September 3, 2011
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulationKyle Ware, Polina Brodsky, Anjali A Satoskar, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 11, 2012
Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?Brad H Rovin, Samir V Parikh, Lee A Hebert, et al.
Pageof 8